Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
Clearside Biomedical has raised $15.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in February 2024.
Clearside Biomedical's investors include Cormorant Asset Management, Perceptive Advisors, Hatteras Venture Partners, HealthCare Royalty Partners, Rock Springs Capital.
Clearside Biomedical is headquartered in Alpharetta, United States.
Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.
Clearside Biomedical is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Clearside Biomedical — Funding & Investors." VCBacked, February 7, 2024, https://www.vcbacked.co/company/clearside-biomedical. Accessed July 19, 2026.
VCBacked. (2024). Clearside Biomedical — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/clearside-biomedical
{{cite web |title=Clearside Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/clearside-biomedical |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated